Home | All intervention

[RDF data]
Intervention #100093 (Drug:oseltamivir (Tamiflu®))

Resource URI: http://static.linkedct.org/resource/intervention/100093
linkedct:description Oseltamivir is supplied as a white powder blend for constitution to a suspension. It is supplied in 100 ml amber glass bottles with 30 g of powder for oral suspension, a plastic adapter, a plastic oral dispenser and a plastic measuring cup. Initially subjects in Cohort I received oseltamivir 30 mg orally twice daily for 5 days. The DSMB recommended on 05-Aug-2009 that weight based dosing of oseltamivir for subjects subsequently enrolled in Cohort I. Based on pharmacokinetic data available as of that date, the initial weight-based dose to be evaluated for Cohort I is 3.5 mg/kg twice a day. Cohort II and Cohort III will receive oseltamivir at 3.0 mg/kg/dose orally twice daily for 5 days. Cohorts IV and V will receive 3.0 mg/kg/dose orally twice daily for 5 days, this dose may be adjusted.
is linkedct:intervention of <http://static.linkedct.org/resource/trials/NCT00391768>
linkedct:intervention_id 100093 (xsd:int)
linkedct:intervention_name oseltamivir (Tamiflu®)
linkedct:intervention_type Drug
rdfs:label Intervention #100093 (Drug:oseltamivir (Tamiflu®))
rdf:type linkedct:intervention